RxDoctor Payments Data

Haidy Lee, MD

Radiation Oncology · Eugene, ORNPI 1922211424

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,125 of the $4,990 with a category attached, or 62.6%. Regeneron accounts for 65.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $3,380, 3.0 times the $1,136 reported in 2020. Among radiation oncology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,990in general payments, 2019–2025

Across 12 payments — averaging $415.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$3K
  • Varian Medical Systems, Inc.$1K
  • Siemens Medical Solutions USA, Inc.$303
  • Regeneron Healthcare Solutions, Inc.$245
  • Merck$36

What the payments were for

  • Consulting fees$3,12563%
  • Travel & lodging$1,20524%
  • Food & beverage$64013%
  • Education$200%

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,990 in reported general payments places this provider in the 90th percentile of 93 radiation oncology providers in Oregon.

See all radiation oncology providers in Oregon

Medicare billing

Part B allowed, 2024
$532,845
Medicare patients
199
Services billed
3,362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine Hcl ViscousLidocaine Hcl13$118

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →